Ginkgo Bioworks Holdings, Inc. Class A DNA
NYSE · United States · Health Services
$12.83+0.87 (+7.27%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.75 | -0.90 | +16.2% | $20.16M | -16.2% | -9.3%$9.37→$8.50 |
| Q1 2026 | 2026-05-07 | -1.39 | -1.34 | -3.7% | — | — | -11.4%$10.08→$8.93 |
| Q4 2025 | 2026-02-26 | -0.77 | -1.11 | +30.6% | — | — | -28.0%$9.38→$6.75 |
| Q3 2025 | 2025-11-06 | -1.45 | -1.24 | -16.9% | — | — | -22.8%$11.59→$8.95 |
| Q2 2025 | 2025-08-07 | -1.10 | -1.57 | +29.9% | — | — | — |
| Q1 2025 | 2025-05-06 | -1.68 | -1.77 | +5.1% | — | — | — |
| Q4 2024 | 2025-02-25 | -1.21 | -1.30 | +6.9% | — | — | — |
| Q3 2024 | 2024-11-12 | -1.08 | -3.32 | +67.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.